Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 522

1.

Adipocytokines and incident diabetes mellitus in older adults: the independent effect of plasminogen activator inhibitor 1.

Kanaya AM, Wassel Fyr C, Vittinghoff E, Harris TB, Park SW, Goodpaster BH, Tylavsky F, Cummings SR.

Arch Intern Med. 2006 Feb 13;166(3):350-6.

PMID:
16476877
2.

Adipocytokines attenuate the association between visceral adiposity and diabetes in older adults.

Kanaya AM, Harris T, Goodpaster BH, Tylavsky F, Cummings SR; Health, Aging, and Body Composition (ABC) Study..

Diabetes Care. 2004 Jun;27(6):1375-80.

3.

Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans.

Boyko EJ, Fujimoto WY, Leonetti DL, Newell-Morris L.

Diabetes Care. 2000 Apr;23(4):465-71.

4.

Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study.

Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL.

Arch Intern Med. 1999 Oct 11;159(18):2151-9.

PMID:
10527292
5.

Association of visceral adipose tissue with incident myocardial infarction in older men and women: the Health, Aging and Body Composition Study.

Nicklas BJ, Penninx BW, Cesari M, Kritchevsky SB, Newman AB, Kanaya AM, Pahor M, Jingzhong D, Harris TB; Health, Aging and Body Composition Study..

Am J Epidemiol. 2004 Oct 15;160(8):741-9.

PMID:
15466496
6.

Risk of type 2 diabetes mellitus in young adults from a biracial community: the Bogalusa Heart Study.

McClain MR, Srinivasan SR, Chen W, Steinmann WC, Berenson GS.

Prev Med. 2000 Jul;31(1):1-7.

PMID:
10896837
7.

Leptin and incident type 2 diabetes: risk or protection?

Schmidt MI, Duncan BB, Vigo A, Pankow JS, Couper D, Ballantyne CM, Hoogeveen RC, Heiss G; ARIC Investigators..

Diabetologia. 2006 Sep;49(9):2086-96.

PMID:
16850292
8.

Plasma plasminogen activator inhibitor-I is associated with plasma leptin irrespective of body mass index, body fat mass, and plasma insulin and metabolic parameters in premenopausal women.

De Mitrio V, De Pergola G, Vettor R, Marino R, Sciaraffia M, Pagano C, Scaraggi FA, Di Lorenzo L, Giorgino R.

Metabolism. 1999 Aug;48(8):960-4.

PMID:
10459558
9.

Visceral adiposity is an independent predictor of incident hypertension in Japanese Americans.

Hayashi T, Boyko EJ, Leonetti DL, McNeely MJ, Newell-Morris L, Kahn SE, Fujimoto WY.

Ann Intern Med. 2004 Jun 15;140(12):992-1000.

PMID:
15197016
10.

Impact of adiposity and plasma adipocytokines on diabetic angiopathies in Japanese Type 2 diabetic subjects.

Matsuda M, Kawasaki F, Yamada K, Kanda Y, Saito M, Eto M, Matsuki M, Kaku K.

Diabet Med. 2004 Aug;21(8):881-8.

PMID:
15270792
11.

Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus.

Yatagai T, Nagasaka S, Taniguchi A, Fukushima M, Nakamura T, Kuroe A, Nakai Y, Ishibashi S.

Metabolism. 2003 Oct;52(10):1274-8.

PMID:
14564678
12.

Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.

Festa A, D'Agostino R Jr, Tracy RP, Haffner SM; Insulin Resistance Atherosclerosis Study..

Diabetes. 2002 Apr;51(4):1131-7.

13.

Serum adiponectin in young adults--interactions with central adiposity, circulating levels of glucose, and insulin resistance: the CARDIA study.

Steffes MW, Gross MD, Schreiner PJ, Yu X, Hilner JE, Gingerich R, Jacobs DR Jr.

Ann Epidemiol. 2004 Aug;14(7):492-8.

PMID:
15301786
14.

Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity.

Ryan AS, Berman DM, Nicklas BJ, Sinha M, Gingerich RL, Meneilly GS, Egan JM, Elahi D.

Diabetes Care. 2003 Aug;26(8):2383-8.

PMID:
12882866
15.

Plasma levels of tumor necrosis factor-alpha (TNF-alpha) are essentially dependent on visceral fat amount in type 2 diabetic patients.

Bertin E, Nguyen P, Guenounou M, Durlach V, Potron G, Leutenegger M.

Diabetes Metab. 2000 May;26(3):178-82.

16.

Normal fasting plasma glucose levels and type 2 diabetes in young men.

Tirosh A, Shai I, Tekes-Manova D, Israeli E, Pereg D, Shochat T, Kochba I, Rudich A; Israeli Diabetes Research Group..

N Engl J Med. 2005 Oct 6;353(14):1454-62. Erratum in: N Engl J Med. 2006 Jun 1;354(22):2401.

17.

Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors.

You T, Yang R, Lyles MF, Gong D, Nicklas BJ.

Am J Physiol Endocrinol Metab. 2005 Apr;288(4):E741-7.

18.
19.

Liver fat content measured by magnetic resonance spectroscopy at 3.0 tesla independently correlates with plasminogen activator inhibitor-1 and body mass index in type 2 diabetic subjects.

Ishii M, Yoshioka Y, Ishida W, Kaneko Y, Fujiwara F, Taneichi H, Miura M, Toshihiro M, Takebe N, Iwai M, Suzuki K, Satoh J.

Tohoku J Exp Med. 2005 May;206(1):23-30.

20.

Normal fasting plasma glucose and risk of type 2 diabetes diagnosis.

Nichols GA, Hillier TA, Brown JB.

Am J Med. 2008 Jun;121(6):519-24. doi: 10.1016/j.amjmed.2008.02.026.

PMID:
18501234

Supplemental Content

Support Center